Alzheimer’s & Dementia: Translational Research & Clinical Interventions (Jan 2022)

Current understanding of AD pathophysiology and impact of amyloid‐beta targeted treatments on biomarkers and clinical endpoints

Ronald C. Petersen,
Ana Graf,
Maria C. Carrillo,
Christopher J. Weber

Affiliations

Ronald C. Petersen: Mayo Clinic Alzheimer's Disease Research Center Rochester Minnesota USA
Ana Graf: Novartis Pharma AG Klybeckstrasse, 4057 Basel Basel Switzerland
Maria C. Carrillo: Alzheimer's Association Chicago Illinois USA
Christopher J. Weber: Alzheimer's Association Chicago Illinois USA

DOI: https://doi.org/10.1002/trc2.12361
Journal volume & issue: Vol. 8, no. 1
pp. n/a – n/a

Abstract

No abstracts available.

Published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions

ISSN: 2352-8737 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system; Medicine: Internal medicine: Special situations and conditions: Geriatrics
Website: https://alz-journals.onlinelibrary.wiley.com/journal/23528737

About the journal